1
DOTAREM Pharmacokinetics and Safety Study in Pediatric Subjects Aged < 2 Years
Condition(s):Magnetic Resonance ImagingLast Updated:March 9, 2017Completed
DOTAREM: 53 Clinical Trials, Page 1 of 6
Hide Studies Not Open or Pending
2
Intra-individual Open-label, Single Center Study to Compare Unenhanced MRI With Dotarem Enhanced MRI
Condition(s):Brain DiseasesLast Updated:May 20, 2022Completed
3
Post-marketing Surveillance Study for Evaluation of Dotarem Safety
Condition(s):Contrast-enhanced MRI With DotaremLast Updated:May 2, 2017Completed
4
Safety and Dialysability of Dotarem® in Dialysed Patients
Condition(s):End-stage Renal FailureLast Updated:July 8, 2015Completed
5
Abbreviated MRI Protocol: Initial Experience With Dotarem® (Gadoterate Meglumine)
Condition(s):Breast Neoplasms; Breast Diseases; Breast Fibroadenoma; Breast CancerLast Updated:October 12, 2021Recruiting
6
Post Marketing Surveillance Study for Evaluation of Efficacy and Safety of Dotarem in Magnetic Resonance Mammography
Condition(s):MR Mammography With DotaremLast Updated:May 2, 2017Completed
7
Crossover Comparison of MultiHance and Dotarem
Condition(s):Brain DiseaseLast Updated:January 10, 2017Completed
8
Efficacy of Dotarem® (Gd-DOTA) Versus Gadovist® (Gd-DO3A-butrol) for Late Gadolinium Enhancement Cardiac Magnetic Resonance
Condition(s):Coronary Artery Disease; CardiomyopathyLast Updated:January 22, 2019Unknown status
9
Carotid and Vertebral Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time Of Flight (TOF)
Condition(s):Cerebral Arterial DiseasesLast Updated:June 16, 2016Completed
10
Carotid and Vertebral Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time Of Flight (TOF)
Condition(s):Cerebral Arterial DiseasesLast Updated:June 16, 2016Completed